Catheter Precision (VTAK) Return on Sales (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Return on Sales data on file, last reported at 0.04% in Q1 2026.

• On a quarterly basis, Return on Sales rose 24.0% year-over-year to 0.04% in Q1 2026; TTM through Mar 2026 was 0.1%, a 21.0% increase from a year earlier, with the FY2025 full-year figure at 0.19%, up 13.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.04%, down from 0.02% in the prior quarter.
• Over the last five years, Return on Sales for VTAK reached as high as 0.02% in Q4 2025 and fell as low as 19.19% in Q4 2022.
• Historically, Return on Sales has averaged 3.68% across 5 years, with a median of 0.3% in 2025.
• Across the five-year window, Return on Sales plunged 1813 bps in 2022 and soared 1914 bps in 2023, its largest moves.
• Year by year, Return on Sales stood at 19.19% in 2022, then jumped by 100 bps to 0.05% in 2023, then tumbled by 219 bps to 0.17% in 2024, then surged by 91 bps to 0.02% in 2025, then slumped by 152 bps to 0.04% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.04% in Q1 2026, 0.02% in Q4 2025, and 0.1% in Q3 2025.